nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—Irinotecan—pancreatic cancer	0.549	1	CbGbCtD
Gallamine Triethiodide—Haemoglobin—Fluorouracil—pancreatic cancer	0.00113	0.00266	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Fluorouracil—pancreatic cancer	0.00112	0.00266	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Fluorouracil—pancreatic cancer	0.00112	0.00265	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00112	0.00264	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Sunitinib—pancreatic cancer	0.00111	0.00262	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Irinotecan—pancreatic cancer	0.00109	0.00257	CcSEcCtD
Gallamine Triethiodide—Cough—Sunitinib—pancreatic cancer	0.00108	0.00255	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00107	0.00254	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00107	0.00252	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00106	0.00251	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Tamoxifen—pancreatic cancer	0.00106	0.0025	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00106	0.0025	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00106	0.00249	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Sunitinib—pancreatic cancer	0.00105	0.00249	CcSEcCtD
Gallamine Triethiodide—Chest pain—Sunitinib—pancreatic cancer	0.00105	0.00249	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00105	0.00247	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00105	0.00247	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00102	0.0024	CcSEcCtD
Gallamine Triethiodide—Fatigue—Tamoxifen—pancreatic cancer	0.00102	0.0024	CcSEcCtD
Gallamine Triethiodide—Pain—Tamoxifen—pancreatic cancer	0.00101	0.00238	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00101	0.00238	CcSEcCtD
Gallamine Triethiodide—Fatigue—Erlotinib—pancreatic cancer	0.00101	0.00238	CcSEcCtD
Gallamine Triethiodide—Pain—Erlotinib—pancreatic cancer	0.000998	0.00236	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000989	0.00234	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Epirubicin—pancreatic cancer	0.000983	0.00232	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Sunitinib—pancreatic cancer	0.000981	0.00232	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.000977	0.00231	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Docetaxel—pancreatic cancer	0.000961	0.00227	CcSEcCtD
Gallamine Triethiodide—Anaemia—Irinotecan—pancreatic cancer	0.000942	0.00223	CcSEcCtD
Gallamine Triethiodide—Urticaria—Tamoxifen—pancreatic cancer	0.000937	0.00221	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Tamoxifen—pancreatic cancer	0.000932	0.0022	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Epirubicin—pancreatic cancer	0.000925	0.00218	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Erlotinib—pancreatic cancer	0.000923	0.00218	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Erlotinib—pancreatic cancer	0.000923	0.00218	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00092	0.00217	CcSEcCtD
Gallamine Triethiodide—Malaise—Irinotecan—pancreatic cancer	0.000919	0.00217	CcSEcCtD
Gallamine Triethiodide—Anaemia—Gemcitabine—pancreatic cancer	0.000918	0.00217	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Irinotecan—pancreatic cancer	0.000913	0.00215	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Doxorubicin—pancreatic cancer	0.00091	0.00215	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Sunitinib—pancreatic cancer	0.000907	0.00214	CcSEcCtD
Gallamine Triethiodide—Anaemia—Fluorouracil—pancreatic cancer	0.000903	0.00213	CcSEcCtD
Gallamine Triethiodide—Malaise—Gemcitabine—pancreatic cancer	0.000896	0.00211	CcSEcCtD
Gallamine Triethiodide—Cough—Irinotecan—pancreatic cancer	0.00089	0.0021	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Gemcitabine—pancreatic cancer	0.000889	0.0021	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Fluorouracil—pancreatic cancer	0.000874	0.00206	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000872	0.00206	CcSEcCtD
Gallamine Triethiodide—Fatigue—Sunitinib—pancreatic cancer	0.000871	0.00206	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000869	0.00205	CcSEcCtD
Gallamine Triethiodide—Cough—Gemcitabine—pancreatic cancer	0.000867	0.00205	CcSEcCtD
Gallamine Triethiodide—Pain—Sunitinib—pancreatic cancer	0.000864	0.00204	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000856	0.00202	CcSEcCtD
Gallamine Triethiodide—Asthenia—Tamoxifen—pancreatic cancer	0.000846	0.002	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Gemcitabine—pancreatic cancer	0.000846	0.002	CcSEcCtD
Gallamine Triethiodide—Chest pain—Gemcitabine—pancreatic cancer	0.000846	0.002	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00084	0.00198	CcSEcCtD
Gallamine Triethiodide—Confusional state—Irinotecan—pancreatic cancer	0.000839	0.00198	CcSEcCtD
Gallamine Triethiodide—Asthenia—Erlotinib—pancreatic cancer	0.000837	0.00198	CcSEcCtD
Gallamine Triethiodide—Pruritus—Tamoxifen—pancreatic cancer	0.000835	0.00197	CcSEcCtD
Gallamine Triethiodide—Chest pain—Fluorouracil—pancreatic cancer	0.000831	0.00196	CcSEcCtD
Gallamine Triethiodide—Pruritus—Erlotinib—pancreatic cancer	0.000826	0.00195	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000815	0.00192	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Docetaxel—pancreatic cancer	0.000814	0.00192	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Docetaxel—pancreatic cancer	0.000812	0.00192	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Docetaxel—pancreatic cancer	0.00081	0.00191	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000807	0.00191	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000806	0.0019	CcSEcCtD
Gallamine Triethiodide—Confusional state—Fluorouracil—pancreatic cancer	0.000804	0.0019	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Sunitinib—pancreatic cancer	0.000799	0.00189	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Sunitinib—pancreatic cancer	0.000799	0.00189	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Erlotinib—pancreatic cancer	0.000798	0.00189	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000794	0.00187	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000789	0.00186	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Gemcitabine—pancreatic cancer	0.000787	0.00186	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00078	0.00184	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Fluorouracil—pancreatic cancer	0.000778	0.00184	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Docetaxel—pancreatic cancer	0.000757	0.00179	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Docetaxel—pancreatic cancer	0.000751	0.00177	CcSEcCtD
Gallamine Triethiodide—Vomiting—Tamoxifen—pancreatic cancer	0.00075	0.00177	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Irinotecan—pancreatic cancer	0.000747	0.00176	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000744	0.00176	CcSEcCtD
Gallamine Triethiodide—Rash—Tamoxifen—pancreatic cancer	0.000744	0.00176	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Tamoxifen—pancreatic cancer	0.000743	0.00175	CcSEcCtD
Gallamine Triethiodide—Vomiting—Erlotinib—pancreatic cancer	0.000742	0.00175	CcSEcCtD
Gallamine Triethiodide—Headache—Tamoxifen—pancreatic cancer	0.000739	0.00174	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000739	0.00174	CcSEcCtD
Gallamine Triethiodide—Rash—Erlotinib—pancreatic cancer	0.000736	0.00174	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Erlotinib—pancreatic cancer	0.000735	0.00174	CcSEcCtD
Gallamine Triethiodide—Headache—Erlotinib—pancreatic cancer	0.000731	0.00173	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.00073	0.00172	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000728	0.00172	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000726	0.00171	CcSEcCtD
Gallamine Triethiodide—Asthenia—Sunitinib—pancreatic cancer	0.000725	0.00171	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000721	0.0017	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000718	0.0017	CcSEcCtD
Gallamine Triethiodide—Fatigue—Irinotecan—pancreatic cancer	0.000717	0.00169	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000716	0.00169	CcSEcCtD
Gallamine Triethiodide—Pruritus—Sunitinib—pancreatic cancer	0.000715	0.00169	CcSEcCtD
Gallamine Triethiodide—Pain—Irinotecan—pancreatic cancer	0.000712	0.00168	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000706	0.00167	CcSEcCtD
Gallamine Triethiodide—Nausea—Tamoxifen—pancreatic cancer	0.000701	0.00165	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0007	0.00165	CcSEcCtD
Gallamine Triethiodide—Fatigue—Gemcitabine—pancreatic cancer	0.000699	0.00165	CcSEcCtD
Gallamine Triethiodide—Pain—Gemcitabine—pancreatic cancer	0.000693	0.00164	CcSEcCtD
Gallamine Triethiodide—Nausea—Erlotinib—pancreatic cancer	0.000693	0.00164	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Sunitinib—pancreatic cancer	0.000691	0.00163	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Docetaxel—pancreatic cancer	0.00069	0.00163	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000688	0.00162	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000686	0.00162	CcSEcCtD
Gallamine Triethiodide—Pain—Fluorouracil—pancreatic cancer	0.000682	0.00161	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—pancreatic cancer	0.000676	0.00159	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000668	0.00158	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000667	0.00158	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Irinotecan—pancreatic cancer	0.000658	0.00155	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Irinotecan—pancreatic cancer	0.000658	0.00155	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000657	0.00155	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000653	0.00154	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—pancreatic cancer	0.000651	0.00154	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—pancreatic cancer	0.000648	0.00153	CcSEcCtD
Gallamine Triethiodide—Vomiting—Sunitinib—pancreatic cancer	0.000642	0.00152	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gemcitabine—pancreatic cancer	0.000641	0.00151	CcSEcCtD
Gallamine Triethiodide—Rash—Sunitinib—pancreatic cancer	0.000637	0.0015	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Sunitinib—pancreatic cancer	0.000636	0.0015	CcSEcCtD
Gallamine Triethiodide—Urticaria—Fluorouracil—pancreatic cancer	0.000633	0.00149	CcSEcCtD
Gallamine Triethiodide—Headache—Sunitinib—pancreatic cancer	0.000633	0.00149	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—pancreatic cancer	0.000631	0.00149	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Fluorouracil—pancreatic cancer	0.00063	0.00149	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—pancreatic cancer	0.000625	0.00148	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—pancreatic cancer	0.000615	0.00145	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000613	0.00145	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—pancreatic cancer	0.0006	0.00142	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—pancreatic cancer	0.0006	0.00142	CcSEcCtD
Gallamine Triethiodide—Nausea—Sunitinib—pancreatic cancer	0.0006	0.00142	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—pancreatic cancer	0.0006	0.00142	CcSEcCtD
Gallamine Triethiodide—Asthenia—Irinotecan—pancreatic cancer	0.000597	0.00141	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000596	0.00141	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000587	0.00139	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gemcitabine—pancreatic cancer	0.000582	0.00137	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—pancreatic cancer	0.00058	0.00137	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gemcitabine—pancreatic cancer	0.000574	0.00135	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Irinotecan—pancreatic cancer	0.000569	0.00134	CcSEcCtD
Gallamine Triethiodide—Pruritus—Fluorouracil—pancreatic cancer	0.000564	0.00133	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000563	0.00133	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—pancreatic cancer	0.000561	0.00133	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—pancreatic cancer	0.000559	0.00132	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000555	0.00131	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—pancreatic cancer	0.000549	0.0013	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—pancreatic cancer	0.000548	0.00129	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—pancreatic cancer	0.000546	0.00129	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000545	0.00129	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000543	0.00128	CcSEcCtD
Gallamine Triethiodide—Vomiting—Irinotecan—pancreatic cancer	0.000529	0.00125	CcSEcCtD
Gallamine Triethiodide—Rash—Irinotecan—pancreatic cancer	0.000525	0.00124	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Irinotecan—pancreatic cancer	0.000524	0.00124	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000524	0.00124	CcSEcCtD
Gallamine Triethiodide—Headache—Irinotecan—pancreatic cancer	0.000521	0.00123	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—pancreatic cancer	0.000517	0.00122	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gemcitabine—pancreatic cancer	0.000515	0.00122	CcSEcCtD
Gallamine Triethiodide—Rash—Gemcitabine—pancreatic cancer	0.000511	0.00121	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gemcitabine—pancreatic cancer	0.000511	0.00121	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—pancreatic cancer	0.00051	0.0012	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—pancreatic cancer	0.000508	0.0012	CcSEcCtD
Gallamine Triethiodide—Headache—Gemcitabine—pancreatic cancer	0.000508	0.0012	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—pancreatic cancer	0.000507	0.0012	CcSEcCtD
Gallamine Triethiodide—Vomiting—Fluorouracil—pancreatic cancer	0.000507	0.0012	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—pancreatic cancer	0.000507	0.0012	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—pancreatic cancer	0.000505	0.00119	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000503	0.00119	CcSEcCtD
Gallamine Triethiodide—Rash—Fluorouracil—pancreatic cancer	0.000503	0.00119	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Fluorouracil—pancreatic cancer	0.000502	0.00119	CcSEcCtD
Gallamine Triethiodide—Headache—Fluorouracil—pancreatic cancer	0.000499	0.00118	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000497	0.00117	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—pancreatic cancer	0.000496	0.00117	CcSEcCtD
Gallamine Triethiodide—Nausea—Irinotecan—pancreatic cancer	0.000494	0.00117	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—pancreatic cancer	0.000492	0.00116	CcSEcCtD
Gallamine Triethiodide—Nausea—Gemcitabine—pancreatic cancer	0.000481	0.00114	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000474	0.00112	CcSEcCtD
Gallamine Triethiodide—Nausea—Fluorouracil—pancreatic cancer	0.000473	0.00112	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—pancreatic cancer	0.000472	0.00111	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000469	0.00111	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—pancreatic cancer	0.000466	0.0011	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—pancreatic cancer	0.000455	0.00107	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—pancreatic cancer	0.000455	0.00107	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—pancreatic cancer	0.000439	0.00104	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000431	0.00102	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—pancreatic cancer	0.000429	0.00101	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—pancreatic cancer	0.000426	0.001	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000424	0.001	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—pancreatic cancer	0.000415	0.000979	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—pancreatic cancer	0.000413	0.000974	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—pancreatic cancer	0.000407	0.000961	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—pancreatic cancer	0.000407	0.00096	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—pancreatic cancer	0.000405	0.000956	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—pancreatic cancer	0.000405	0.000956	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000402	0.000949	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—pancreatic cancer	0.000397	0.000937	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—pancreatic cancer	0.000394	0.00093	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—pancreatic cancer	0.000394	0.000929	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—pancreatic cancer	0.000391	0.000924	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—pancreatic cancer	0.000384	0.000906	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00038	0.000897	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—pancreatic cancer	0.000379	0.000894	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—pancreatic cancer	0.000377	0.00089	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—pancreatic cancer	0.000375	0.000884	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—pancreatic cancer	0.000375	0.000884	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000372	0.000878	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—pancreatic cancer	0.000366	0.000864	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—pancreatic cancer	0.000363	0.000856	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—pancreatic cancer	0.000362	0.000856	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—pancreatic cancer	0.000362	0.000855	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—pancreatic cancer	0.00036	0.000851	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000354	0.000835	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000352	0.00083	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—pancreatic cancer	0.00035	0.000827	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—pancreatic cancer	0.000349	0.000823	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—pancreatic cancer	0.000348	0.000823	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—pancreatic cancer	0.000342	0.000807	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000335	0.000791	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—pancreatic cancer	0.000335	0.00079	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—pancreatic cancer	0.000332	0.000783	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000327	0.000772	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000322	0.000761	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—pancreatic cancer	0.00032	0.000755	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00031	0.000732	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—pancreatic cancer	0.00031	0.000731	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—pancreatic cancer	0.000308	0.000728	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—pancreatic cancer	0.000307	0.000725	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—pancreatic cancer	0.000307	0.000724	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—pancreatic cancer	0.000307	0.000724	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000296	0.000698	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000286	0.000675	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—pancreatic cancer	0.000285	0.000673	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000284	0.00067	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000284	0.00067	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—pancreatic cancer	0.000278	0.000657	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—pancreatic cancer	0.000275	0.000648	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—pancreatic cancer	0.000265	0.000627	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000265	0.000624	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—pancreatic cancer	0.000258	0.000608	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—pancreatic cancer	0.000254	0.0006	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—pancreatic cancer	0.000247	0.000582	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000246	0.00058	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—pancreatic cancer	0.000245	0.000578	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—pancreatic cancer	0.000244	0.000577	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—pancreatic cancer	0.000243	0.000574	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—pancreatic cancer	0.00023	0.000544	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—pancreatic cancer	0.000228	0.000539	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—pancreatic cancer	0.000226	0.000534	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—pancreatic cancer	0.000226	0.000534	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—pancreatic cancer	0.000225	0.000531	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—pancreatic cancer	0.000213	0.000503	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of proteins—FUT8—pancreatic cancer	0.000197	0.00719	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—CXCL8—pancreatic cancer	0.000196	0.00715	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000196	0.00714	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000192	0.00702	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.000192	0.00699	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.000184	0.00673	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—CCND1—pancreatic cancer	0.000183	0.00666	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.000178	0.0065	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.000171	0.00625	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000165	0.00601	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.000164	0.00599	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.000161	0.00588	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.000158	0.00577	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000157	0.00573	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PRLHR—pancreatic cancer	0.000153	0.0056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.000153	0.00557	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000149	0.00544	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR2—pancreatic cancer	0.000145	0.00531	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000144	0.00527	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000142	0.00517	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000135	0.00493	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.000135	0.00493	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CG—pancreatic cancer	0.000135	0.00492	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.000133	0.00485	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SSTR3—pancreatic cancer	0.00013	0.00476	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SSTR1—pancreatic cancer	0.000125	0.00456	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PPY—pancreatic cancer	0.000123	0.00447	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PCSK1—pancreatic cancer	0.00012	0.00439	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SSTR2—pancreatic cancer	0.00012	0.00439	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.000119	0.00433	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CD—pancreatic cancer	0.000119	0.00433	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCKBR—pancreatic cancer	0.000116	0.00424	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.000116	0.00422	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.000114	0.00415	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—SST—pancreatic cancer	0.000113	0.00413	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000113	0.00411	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.00011	0.00402	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000107	0.00392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CNR1—pancreatic cancer	0.000104	0.00381	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CB—pancreatic cancer	0.000103	0.00377	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000103	0.00375	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	9.69e-05	0.00354	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SCT—pancreatic cancer	9.47e-05	0.00346	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	9.43e-05	0.00344	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	9.32e-05	0.0034	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCK—pancreatic cancer	9.04e-05	0.0033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	8.99e-05	0.00328	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PTEN—pancreatic cancer	8.93e-05	0.00326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	8.93e-05	0.00326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR2—pancreatic cancer	8.81e-05	0.00321	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GLP1R—pancreatic cancer	8.81e-05	0.00321	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCKAR—pancreatic cancer	8.66e-05	0.00316	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—pancreatic cancer	8.62e-05	0.00315	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGF—pancreatic cancer	8.52e-05	0.00311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	8.3e-05	0.00303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SHH—pancreatic cancer	7.9e-05	0.00288	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	7.9e-05	0.00288	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRLHR—pancreatic cancer	7.87e-05	0.00287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—IAPP—pancreatic cancer	7.8e-05	0.00285	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRSS1—pancreatic cancer	7.69e-05	0.00281	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	7.65e-05	0.00279	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—pancreatic cancer	7.58e-05	0.00276	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTCH1—pancreatic cancer	7.49e-05	0.00273	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—PTHLH—pancreatic cancer	7.49e-05	0.00273	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SSTR3—pancreatic cancer	7.37e-05	0.00269	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	7.33e-05	0.00267	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GDI2—pancreatic cancer	7.21e-05	0.00263	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GDI1—pancreatic cancer	7.21e-05	0.00263	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	7.13e-05	0.0026	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	7.06e-05	0.00258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SSTR1—pancreatic cancer	7.06e-05	0.00258	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	7e-05	0.00256	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PPY—pancreatic cancer	6.93e-05	0.00253	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	6.89e-05	0.00251	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—SST—pancreatic cancer	6.85e-05	0.0025	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SSTR2—pancreatic cancer	6.8e-05	0.00248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SSTR3—pancreatic cancer	6.69e-05	0.00244	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ARG2—pancreatic cancer	6.67e-05	0.00243	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—pancreatic cancer	6.6e-05	0.00241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCKBR—pancreatic cancer	6.57e-05	0.0024	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SSTR1—pancreatic cancer	6.41e-05	0.00234	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.39e-05	0.00233	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GCG—pancreatic cancer	6.32e-05	0.00231	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR1—pancreatic cancer	6.32e-05	0.00231	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	6.3e-05	0.0023	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPY—pancreatic cancer	6.29e-05	0.0023	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	6.22e-05	0.00227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SSTR2—pancreatic cancer	6.17e-05	0.00225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	6.12e-05	0.00223	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GCG—pancreatic cancer	6.1e-05	0.00223	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCKBR—pancreatic cancer	5.96e-05	0.00218	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	5.85e-05	0.00214	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMP—pancreatic cancer	5.83e-05	0.00213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGTR1—pancreatic cancer	5.82e-05	0.00213	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.72e-05	0.00209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.71e-05	0.00208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GAST—pancreatic cancer	5.65e-05	0.00206	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	5.64e-05	0.00206	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.6e-05	0.00204	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—HRAS—pancreatic cancer	5.37e-05	0.00196	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SCT—pancreatic cancer	5.35e-05	0.00195	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.33e-05	0.00195	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.29e-05	0.00193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	5.13e-05	0.00187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	5.11e-05	0.00186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	5.09e-05	0.00186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	4.98e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	4.98e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4.97e-05	0.00181	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	4.9e-05	0.00179	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	4.86e-05	0.00177	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.86e-05	0.00177	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.81e-05	0.00176	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GLP1R—pancreatic cancer	4.7e-05	0.00172	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.7e-05	0.00172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	4.65e-05	0.0017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	4.64e-05	0.00169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	4.64e-05	0.00169	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—DPYD—pancreatic cancer	4.62e-05	0.00169	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	4.52e-05	0.00165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	4.52e-05	0.00165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	4.45e-05	0.00162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	4.41e-05	0.00161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	4.41e-05	0.00161	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A2—pancreatic cancer	4.39e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	4.38e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	4.37e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	4.37e-05	0.0016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.34e-05	0.00158	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.33e-05	0.00158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	4.26e-05	0.00155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	4.23e-05	0.00154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.19e-05	0.00153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	4.05e-05	0.00148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	4.03e-05	0.00147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	4e-05	0.00146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.97e-05	0.00145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	3.95e-05	0.00144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	3.95e-05	0.00144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	3.87e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	3.84e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	3.84e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.82e-05	0.00139	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	3.79e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPY—pancreatic cancer	3.72e-05	0.00136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	3.65e-05	0.00133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	3.57e-05	0.0013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	3.52e-05	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—SST—pancreatic cancer	3.51e-05	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.5e-05	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	3.45e-05	0.00126	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD44—pancreatic cancer	3.4e-05	0.00124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.33e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—pancreatic cancer	3.32e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—pancreatic cancer	3.32e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	3.31e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	3.31e-05	0.00121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.3e-05	0.0012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	3.29e-05	0.0012	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCG—pancreatic cancer	3.26e-05	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	3.24e-05	0.00118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	3.22e-05	0.00118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	3.22e-05	0.00118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	3.13e-05	0.00114	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	3.1e-05	0.00113	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—STK11—pancreatic cancer	3.06e-05	0.00112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAST—pancreatic cancer	3.03e-05	0.00111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	2.99e-05	0.00109	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.88e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SCT—pancreatic cancer	2.87e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	2.87e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—pancreatic cancer	2.76e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCK—pancreatic cancer	2.74e-05	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	2.67e-05	0.000974	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	2.67e-05	0.000974	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	2.67e-05	0.000974	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMS—pancreatic cancer	2.63e-05	0.000962	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	2.63e-05	0.000959	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.55e-05	0.00093	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	2.55e-05	0.00093	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	2.51e-05	0.000916	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SHH—pancreatic cancer	2.39e-05	0.000874	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	2.38e-05	0.000869	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	2.36e-05	0.000863	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	2.27e-05	0.000829	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	2.27e-05	0.000829	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—pancreatic cancer	2.14e-05	0.000782	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SST—pancreatic cancer	2.08e-05	0.000758	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.05e-05	0.000747	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	2.03e-05	0.000742	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.03e-05	0.00074	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	2.02e-05	0.000738	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—pancreatic cancer	1.93e-05	0.000706	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	1.92e-05	0.000699	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—pancreatic cancer	1.87e-05	0.000681	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.86e-05	0.000679	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GCG—pancreatic cancer	1.85e-05	0.000675	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.8e-05	0.000657	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	1.77e-05	0.000644	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STK11—pancreatic cancer	1.74e-05	0.000635	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—pancreatic cancer	1.7e-05	0.00062	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.63e-05	0.000597	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.57e-05	0.000573	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	1.52e-05	0.000556	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.51e-05	0.00055	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HES1—pancreatic cancer	1.49e-05	0.000543	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—pancreatic cancer	1.48e-05	0.000541	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—pancreatic cancer	1.47e-05	0.000536	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.42e-05	0.00052	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	1.37e-05	0.0005	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.3e-05	0.000476	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTEN—pancreatic cancer	1.28e-05	0.000467	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.25e-05	0.000455	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.24e-05	0.000454	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.22e-05	0.000444	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.19e-05	0.000435	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.13e-05	0.000414	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.12e-05	0.00041	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.1e-05	0.000401	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.1e-05	0.000401	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.09e-05	0.000396	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	1e-05	0.000365	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	9.66e-06	0.000352	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.57e-06	0.000349	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	9.45e-06	0.000345	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—pancreatic cancer	9.03e-06	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	8.69e-06	0.000317	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	8.42e-06	0.000307	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	8.09e-06	0.000295	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	8.04e-06	0.000293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	7.81e-06	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	7.74e-06	0.000283	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	7.54e-06	0.000275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	7.46e-06	0.000272	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—pancreatic cancer	7.38e-06	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	7.32e-06	0.000267	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	7.27e-06	0.000265	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	7.1e-06	0.000259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—pancreatic cancer	6.75e-06	0.000246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	6.57e-06	0.00024	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	6.51e-06	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	6.49e-06	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—pancreatic cancer	6.04e-06	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	6.03e-06	0.00022	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	5.91e-06	0.000216	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	5.59e-06	0.000204	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	5.13e-06	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—pancreatic cancer	4.96e-06	0.000181	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	4.75e-06	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	4.19e-06	0.000153	CbGpPWpGaD
